Page last updated: 2024-08-26

imipenem, anhydrous and Intestinal Diseases

imipenem, anhydrous has been researched along with Intestinal Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gonçalves Junior, I; Kobayasi, S; Naresse, LE; Rodrigues, MA1
Babinchak, T; Dartois, N; Ellis-Grosse, E; Loh, E; Rose, GM1

Trials

1 trial(s) available for imipenem, anhydrous and Intestinal Diseases

ArticleYear
The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Sep-01, Volume: 41 Suppl 5

    Topics: Adult; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Humans; Imipenem; Intestinal Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Tigecycline

2005

Other Studies

1 other study(ies) available for imipenem, anhydrous and Intestinal Diseases

ArticleYear
Diclofenac sodium and Imipenem action on rat intestinal mucosa: a biomechanical and histological study.
    Acta cirurgica brasileira, 2012, Volume: 27, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Imipenem; Intestinal Diseases; Intestinal Mucosa; Intestine, Small; Male; Random Allocation; Rats; Rats, Wistar; Time Factors; Ulcer

2012